MedTrace Logo

Use of Clonidine to Prevent Withdrawal Following Prolonged Dexmedetomidine Infusions

NCT02404077 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 712

Last updated 2017-04-20

No results posted yet for this study

Summary

The investigators' clinical practice makes use of oral clonidine as a means of transitioning from intravenous dexmedetomidine following prolonged infusions (more than 3-5 days). Although this is common clinical practice, there is limited clinical data to demonstrate the efficacy of this technique and to provide clonidine dosing guidelines. The purpose of this study is to retrospectively review the investigators' experience with the use of oral clonidine to prevent withdrawal following the prolonged administration of dexmedetomidine.

Conditions

  • Sedation

Interventions

DRUG

Clonidine

Sponsors & Collaborators

  • Joseph D. Tobias

    lead OTHER

Principal Investigators

  • Joseph D Tobias, MD · Nationwide Children's Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2017-03-31
Completion
2017-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02404077 on ClinicalTrials.gov